Skip to main content

Technological Advancements play Crucial Role in Future of Big Data in Healthcare Market

big data in healthcare market

 

The global healthcare industry is expected to significantly benefit from the growth in the adoption of big data technologies. The advantages of the technology are immense and proven. Future growth is expected to be driven by more countries and their healthcare systems going digital and focusing on data-driven healthcare. The healthcare industry is expected to be significantly boosted by the growing demand for evidence-based clinical care in developing countries. Technological advancements anticipated from 2022 to 2031 are expected to play a crucial role in deciding the future of big data in healthcare market and the level of adoption. Currently, the market growth is hampered by a large volume of unstructured data, slow pace of adoption of digital health in some emerging countries, and lack of sufficient rules and regulations to support mass adoption in emerging countries.

The global big data in healthcare market was valued at $32,925.1 million in 2021 and is anticipated to grow to $130,132.1 million by the end of 2031 at a projected CAGR of 13.96% during the forecast period 2022-2031. The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no overall impact on the market due to any potential COVID-19 waves in the future.

BIS Research big data in healthcare market


Impact of COVID- 19 on the Global Big Data in Healthcare Market

Immediately after the outbreak of COVID-19, the focus of healthcare systems across the globe switched to managing the crisis caused by the pandemic. This led to hospital budgets shrinking. Elective treatments were delayed, refocusing efforts toward the treatment of COVID-19 patients. During the initial phase of the pandemic, several fields in healthcare faced losses due to a decline in visitations. Big data has been at the center of innovation related to COVID-19 treatments in 2020 and 2021. Established players, emerging startups, hospitals, and research facilities have made use of big data to solve the challenges posed by the COVID-19 pandemic. The demand for real-world evidence grew significantly during the COVID-19 pandemic phase.

 Addressable Market Size and Forecast based on Region

 The North America region has one of the most technologically advanced healthcare systems globally. The U.S. government has launched incentive-based programs to encourage providers and payers to implement information technology in their health systems. These initiatives are shifting the market toward a value-based care model as opposed to fee-for-service model.

Europe is one of the early adopters of systems based on technologies such as artificial intelligence and machine learning. These technologies have great potential to aid healthcare professionals in providing improved patient-specific care.

The Asia-Pacific region consists of many emerging economies that are undergoing significant technological advancements along with improvements in their healthcare systems. In many emerging countries in the Asia-Pacific region, the healthcare sector is getting more attention than in the past. Countries such as India and China have several digital health initiatives which have witnessed accelerated implementation during the COVID-19 pandemic.

Big Data in Healthcare Market


Key Competitors in the Global Big Data in Healthcare Market

 The major companies operating in the big data in healthcare market are McKesson, Epic Systems Corporation, and Cerner Corporation. In terms of technological development, most of the players in the market are focused on increasing the volume of structured data and enhancing the interoperability of the available data.

Different Regions Expected to Perform in terms of Market Growth

 Currently, the North America and Europe markets are leading in terms of value. According to primary discussions conducted by BIS Research, currently, efforts are focused on making more of the healthcare data interoperable and fit for data analytics and insights extraction. The Asia-Pacific big data in healthcare market has substantial scope for growth during the forecast period 2022-2031. Growth in support for digital health from local governments is expected to be the first big and crucial step toward increasing the adoption of big data in healthcare in emerging countries during 2022-2031.

RELATED MARKET REPORTS

Global AI in Healthcare Market

Global Clinical Decision Support Systems (CDSS) Market


ABOUT BIS HEALTHCARE

 BIS healthcare vertical offers intelligence in the healthcare technology market for precision medicine, robotics and imaging, life sciences and biopharma, medical devices, digital health, and other emerging healthcare technologies, covering the entire industry spectrum. In the past eight years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating ‘Top 25 Voices’ in precision medicine on its InsightMonk platform for the past two years successfully.



Comments

Popular posts from this blog

Pharmacogenomics Services Market Dynamics, Competitive Landscape & Forecast to 2031

  BIS healthcare experts have found the pharmacogenomics services industry to be one of the most rapidly evolving and dynamic markets. The global  pharmacogenomics services market  is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031. The market is driven by certain factors, including increasing prevalence of infectious diseases and various types of cancer, increasing adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogenomics for drug discovery and development. Currently, the pharmacogenomics services industry is witnessing an upsurge due to the increasing prevalence of infectious diseases and various types of cancer, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogen...

Oncolytic Virus Therapies Market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030

  The global oncolytic virus therapies market is undergoing a significant flux with regard to the advancements that have already taken place and are currently invading the market space. Additionally, with the emergence of virus therapeutics, there is an immense potential for these emerging sub-markets to continue fueling the overall oncolytic virus therapies market. This chapter reviews the significant drivers and restraints that are considerably impacting the dynamicity of the global oncolytic virus therapies market. Due to the ever-rising incidence of cancers, the need for better products and services is becoming more evident. Several key players are aligning their technologies as per the market requirements to provide technologically advanced products and services by adopting inorganic strategies such as agreements, partnerships, and collaborations. The global oncolytic virus therapies market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030 and reach ...

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applic...